Michael Gwarisa
Israel’s Prime Minister, Benjamin Netanyau was diagnosed with early-stage prostate cancer following routine post-surgical monitoring, but doctors say treatment was successful and the lesion has completely disappeared.
According to an official medical report dated April 20, 2026, the Prime Minister had previously undergone treatment on December 29, 2024, for benign enlargement of the prostate, a common non-cancerous condition affecting older men.
Doctors said the initial procedure was completed successfully without complications. However, during a follow-up MRI conducted as part of annual monitoring, specialists detected a very small lesion measuring less than one centimetre with suspicious characteristics in the prostate.
Further examinations confirmed that the lesion represented early-stage prostate cancer.
Medical experts noted that the cancer was detected at a very early stage, with no evidence of metastasis or spread to other parts of the body. They said all additional tests confirmed the cancer remained highly localized.
Doctors explained that in such cases, patients may either remain under close observation or undergo short, targeted radiation therapy. The Prime Minister opted for treatment.
The report states that the treatment was carried out under the supervision of Prof. Aharon Popovtzer, alongside Dr. Mark Igova and Dr. Shraga Gross at Hadassah Medical Center.
According to the medical team, the treatment was fully successful, resulting in the complete disappearance of the lesion. Imaging scans and laboratory tests reportedly confirmed there was no remaining evidence of disease.
The update is likely intended to reassure the public about the Prime Minister’s health status and ability to continue carrying out official duties.
